mossjМосковский хирургический журналMoscow Surgical Journal2072-3180ООО «ПРОФИЛЬ – 2С»10.17238/2072-3180-2022-71-78mossj-619Research ArticleСтатьиАктуальные хирургические методы лечения гиперплазии предстательной железыSurgical methods for benign prostatic hyperplasia treatment. Literature reviewhttps://orcid.org/0000-0003-0680-9460ШиряевА. А.ShiryaevA. A.

Ширяев Арсений Александрович – аспирант кафедры урологии

127473, Москва, ул. Делегатская, д.20, стр.1

Shiryaev Arseniy Alexandrovich – Department of Urology Resident

127473, Moscow

127206, Moscow

https://orcid.org/0000-0003-3299-0574ГоворовА. В.GovorovA. V.

Говоров Александр Викторович – д.м.н., профессор РАН, профессор кафедры урологии; врач-уролог

27206, Москва, ул. Вучетича, д. 21

Govorov Alexander Viktorovich – Dr.Med.Sci., Professor at the Department of Urology

127473, Moscow

127206, Moscow

dr.govorov@gmail.comhttps://orcid.org/0000-0001-5468-0011ВасильевА. О.VasilievA. O.

Васильев Александр Олегович – к.м.н., ассистент кафедрыурологии; врач-уролог; врач-методист

127206, Россия, Москва, ул. Вучетича, д. 21

115088, Москва

Vasiliev Alexander Olegovich – PHD, assistant of the Department of Urology

127473, Moscow

127206, Moscow

115088, Moscow

https://orcid.org/0000-0001-8533-9203СоловьевВ. В.SolovyovV. V.

Соловьев Владимир Викторович – к.м.н., врач-уролог; врач-методист

117545, Москва

117545, Москва, ул. Подольских курсантов, д. 2, корп. 2

Solovyov Vladimir Viktorovich – PHD, doctor urologist

115088, Moscow

117545, Moscow

https://orcid.org/0000-0002-6096-5723ПушкарьД. Ю.PushkarD. Yu.

Пушкарь Дмитрий Юрьевич – академик РАН, д.м.н., профессор, заведующий кафедрой урологии

127473, Москва, ул. Вучетича, д. 21

Pushkar Dmitry Yuryevich – Dr.Med.Sci., Prof., Head of the Department of Urology

127473, Moscow

127206, Moscow

ФГБОУ ВО «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Минздрава России; ГБУЗ ГКБ им. С.И. Спасокукоцкого Департамента здравоохранения г. МосквыРоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry; City Clinical Hospital n.a. S.I. SpasokukotskyRussian FederationФГБОУ ВО «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Минздрава России; ГБУЗ ГКБ им. С.И. Спасокукоцкого Департамента здравоохранения г. Москвы; ГБУ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента» Департамента здравоохранения г. МосквыРоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry; City Clinical Hospital n.a. S.I. Spasokukotsky; Research Institute for Healthcare Organization and Medical ManagementRussian FederationГБУ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента» Департамента здравоохранения г. Москвы; ГБУ3 «Городская поликлиника № 170» Департамента здравоохранения города МосквыРоссияResearch Institute for Healthcare Organization and Medical Management; City Polyclinic № 170Russian Federation20220601202305Специальный выпуск7179Copyright © Ширяев А.А., Говоров А.В., Васильев А.О., Соловьев В.В., Пушкарь Д.Ю., 20232023Ширяев А.А., Говоров А.В., Васильев А.О., Соловьев В.В., Пушкарь Д.Ю.Shiryaev A.A., Govorov A.V., Vasiliev A.O., Solovyov V.V., Pushkar D.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.mossj.ru/jour/article/view/619

Доброкачественная гиперплазия предстательной железы (ДГПЖ) является одним из наиболее распространенных состояний, поражающих мужчин среднего возраста. До 15–25% мужчин в возрасте от 50 до 65 лет имеют симптомы нижних мочевыводящих путей (СНМП), которые обычно связаны с доброкачественным разрастанием ткани предстательной железы. Хотя СНМП часто ассоциируются с ДГПЖ, СНМП также могут быть вызваны различными не связанными синдромами, такими как сердечная недостаточность, инфекции мочевыводящих путей и сахарный диабет. В данной статье проведен обзор публикаций по теме современных и актуальных методов лечения гиперплазии простаты, а также проведен анализ их эффективности и безопасности. Появление большого количества хирургических методов лечения гиперплазии простаты предопределило поиск наиболее эффективных и безопасных из них. Данные проведенного нами проспективного, сравнительного исследования на кафедре урологии МГМСУ имени А.И. Евдокимова на базе ГКБ имени С.И. Спасокукоцкого позволили резюмировать, что все представленные в данной статье методы хирургического лечения ДГПЖ продемонстрировали свою эффективность, но, при этом, только методики тулиевой энуклеации и ТУРП позволяют провести операцию эндоскопически, сохраняя целостность кожных покровов, безопасно и радикально.   

Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting middle-aged men. Up to 15–25% of men aged 50 to 65 years have symptoms of the lower urinary tract (LUP), which are usually associated with benign growth of prostate tissue. Although LUTs are often associated with BPH, LUTs can also be caused by various unrelated syndromes, such as heart failure, urinary tract infections, and diabetes mellitus. This article provides a review of publications on the topic of modern and current methods of treatment of prostate hyperplasia, as well as an analysis of their effectiveness and safety. The emergence of a large number of surgical methods for the treatment of prostate hyperplasia predetermined the search for the most effective and safe of them. The data of a prospective, comparative study conducted by us at the Department of Urology of the Moscow State Medical University named after A.I. Evdokimov on the basis of the State Medical University named after S.I. Spasokukotsky allowed us to summarize that all the methods of surgical treatment of BPH presented in this article have demonstrated their effectiveness, but, at the same time, only the methods of tulium enucleation and TURP allow the operation to be performed endoscopically, preserving the integrity of the skin, safely and radically.

гиперплазияпредстательная железыхирургические методы лечениятрансуретральная резекцияhyperplasiaprostatesurgical methods of treatmenttransurethral prostate resectionИсследование проведено в рамках проекта Департамента здравоохранения города Москвы «Научная лаборатория «Московская поликлиника».The study was conducted within the framework of the project of the Moscow Department of Health "Scientific Laboratory "Moscow Polyclinic".ReferencesMahon J., McVary K. New alternative treatments for lower urinary tract symptoms secondary to benign prostatic hyperplasia. In: Minimally Invasive Urology: An Essential Clinical Guide to Endourology, Laparoscopy, LESS and Robotics, 2nd edn, Best SL, Nakada SY (Eds): Springer, 2020.Mahon J., McVary K. New alternative treatments for lower urinary tract symptoms secondary to benign prostatic hyperplasia. In: Minimally Invasive Urology: An Essential Clinical Guide to Endourology, Laparoscopy, LESS and Robotics, 2nd edn, Best SL, Nakada SY (Eds): Springer, 2020.Foster H., Dahm P., Kohler T. Surgical Management of Lower Uri­nary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. J Urol, 2019, № 202, pp. 592–598. https://doi.org/10.1097/JU.0000000000000319Foster H., Dahm P., Kohler T. Surgical Management of Lower Uri­nary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. J Urol, 2019, № 202, pp. 592–598. https://doi.org/10.1097/JU.0000000000000319Wei J., Calhoun E., Jacobsen S. Urologic diseases in America project: benign prostatic hyperplasia. J Urol, 2005, № 173, pp. 1256–1261. https://doi.org/10.1097/01.ju.0000155709.37840.feWei J., Calhoun E., Jacobsen S. Urologic diseases in America project: benign prostatic hyperplasia. J Urol, 2005, № 173, pp. 1256–1261. https://doi.org/10.1097/01.ju.0000155709.37840.feWelliver C., Feinstein L., Ward J. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project. J Urol, 2020, № 203, pp. 171–178. https://doi.org/10.1097/JU.0000000000000499Welliver C., Feinstein L., Ward J. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project. J Urol, 2020, № 203, pp. 171–178. https://doi.org/10.1097/JU.0000000000000499McVary K., Roehrborn C., Avins A.L. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, № 185, pр. 1793–1803. https://doi.org/10.1016/j.juro.2011.01.074McVary K., Roehrborn C., Avins A.L. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, № 185, pр. 1793–1803. https://doi.org/10.1016/j.juro.2011.01.074Jacobsen S., Jacobson D., Girman C. Natural history of prostatism: risk factors for acute urinary retention. J Urol, 1997, № 158, pp. 481–487. https://doi.org/10.1016/s0022-5347(01)64508-7Jacobsen S., Jacobson D., Girman C. Natural history of prostatism: risk factors for acute urinary retention. J Urol, 1997, № 158, pp. 481–487. https://doi.org/10.1016/s0022-5347(01)64508-7Lightner D., Wymer K., Sanchez J., Kavoussi L. Best Practice State­ment on Urologic Procedures and Antimicrobial Prophylaxis. J Urol, 2020, № 203, pp. 351–356. https://doi.org/10.1097/JU.0000000000000509Lightner D., Wymer K., Sanchez J., Kavoussi L. Best Practice State­ment on Urologic Procedures and Antimicrobial Prophylaxis. J Urol, 2020, № 203, pp. 351–356. https://doi.org/10.1097/JU.0000000000000509Forrest J., Clemens J., Finamore P. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urolog­ic surgery. J Urol, 2009, № 181, pp. 1170–1177. https://doi.org/10.1016/j.juro.2008.12.027Forrest J., Clemens J., Finamore P. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urolog­ic surgery. J Urol, 2009, № 181, pp. 1170–1177. https://doi.org/10.1016/j.juro.2008.12.027Michalski W., Poniatowska G., Jonska-Gmyrek J. Venous thrombo­prophylaxis in urological cancer surgery. Med Oncol, 2019, № 37, pp. 11. https://doi.org/10.1007/s12032-019-1331-8Michalski W., Poniatowska G., Jonska-Gmyrek J. Venous thrombo­prophylaxis in urological cancer surgery. Med Oncol, 2019, № 37, pp. 11. https://doi.org/10.1007/s12032-019-1331-8Borth C., Nickel J. Management of spontaneous prostate related bleeding. AUA: Update Series, 2006Borth C., Nickel J. Management of spontaneous prostate related bleeding. AUA: Update Series, 2006Optimizing Outcomes in Urologic Surgery. American Urological As­sociation: White Paper, 2018.Optimizing Outcomes in Urologic Surgery. American Urological As­sociation: White Paper, 2018.Fwu C., Eggers P., Kirkali Z. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associ­ated with long-term treatment with doxazosin, finasteride and combined therapy. J Urol., 2014, № 191, pp. 1828–1834. https://doi.org/10.1016/j.juro.2013.12.014Fwu C., Eggers P., Kirkali Z. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associ­ated with long-term treatment with doxazosin, finasteride and combined therapy. J Urol., 2014, № 191, pp. 1828–1834. https://doi.org/10.1016/j.juro.2013.12.014American Urological Association (AUA). Guideline. Benign Pros­tatic Hyperplasia: Surgical Management of Benign Prostatic Hyperplasia/ Lower Urinary Tract Symptoms, 2019.American Urological Association (AUA). Guideline. Benign Pros­tatic Hyperplasia: Surgical Management of Benign Prostatic Hyperplasia/ Lower Urinary Tract Symptoms, 2019.Issa M. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol, 2008, № 22, pp. 1589–1595. https://doi.org/10.1089/end.2008.0192Issa M. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol, 2008, № 22, pp. 1589–1595. https://doi.org/10.1089/end.2008.0192Omar M., Lam T., Alexander C. Systematic review and meta-anal­ysis of the clinical effectiveness of bipolar compared with monopolar trans­urethral resection of the prostate (TURP). BJU Int, 2014, № 113, pp. 24–35. https://doi.org/10.1111/bju.12281Omar M., Lam T., Alexander C. Systematic review and meta-anal­ysis of the clinical effectiveness of bipolar compared with monopolar trans­urethral resection of the prostate (TURP). BJU Int, 2014, № 113, pp. 24–35. https://doi.org/10.1111/bju.12281Cornu J., Ahyai S., Bachmann A. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Result­ing from Benign Prostatic Obstruction: An Update. Eur Urol., 2015, № 67, pp. 1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017Cornu J., Ahyai S., Bachmann A. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Result­ing from Benign Prostatic Obstruction: An Update. Eur Urol., 2015, № 67, pp. 1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017Nuhoğlu B., Balci M., Aydin M. The role of bipolar transurethral vaporization in the management of benign prostatic hyperplasia. Urol Int., 2011, № 87, pp. 400–404. https://doi.org/10.1159/000329797Nuhoğlu B., Balci M., Aydin M. The role of bipolar transurethral vaporization in the management of benign prostatic hyperplasia. Urol Int., 2011, № 87, pp. 400–404. https://doi.org/10.1159/000329797Geavlete B., Georgescu D., Multescu R. Bipolar plasma vaporization vs monopolar and bipolar TURP-A prospective, randomized, long-term comparison. Urology, 2011, № 78, pp. 930–935. https://doi.org/10.1016/j.urology.2011.03.072Geavlete B., Georgescu D., Multescu R. Bipolar plasma vaporization vs monopolar and bipolar TURP-A prospective, randomized, long-term comparison. Urology, 2011, № 78, pp. 930–935. https://doi.org/10.1016/j.urology.2011.03.072Lourenco T., Shaw M., Fraser C. The clinical effectiveness of trans­urethral incision of the prostate: a systematic review of randomised con­trolled trials. World J Urol, 2010, № 28, pp. 23–32. https://doi.org/10.1007/s00345-009-0496-8Lourenco T., Shaw M., Fraser C. The clinical effectiveness of trans­urethral incision of the prostate: a systematic review of randomised con­trolled trials. World J Urol, 2010, № 28, pp. 23–32. https://doi.org/10.1007/s00345-009-0496-8Reich O., Gratzke C., Stief C. Techniques and long-term results of surgical procedures for BPH. Eur Urol, 2006, № 49, pp. 970–978. https://doi.org/10.1016/j.eururo.2005.12.072Reich O., Gratzke C., Stief C. Techniques and long-term results of surgical procedures for BPH. Eur Urol, 2006, № 49, pp. 970–978. https://doi.org/10.1016/j.eururo.2005.12.072Lee D., Rieken M., Halpern J. Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients with Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation. Urology, 2016, № 91, pp. 167–173. https://doi.org/10.1016/j.urology.2016.01.021Lee D., Rieken M., Halpern J. Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients with Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation. Urology, 2016, № 91, pp. 167–173. https://doi.org/10.1016/j.urology.2016.01.021Brassetti A., Nunzio C., Delongchamps N. Green light vaporization of the prostate: is it an adult technique? Minerva Urol Nefrol, 2017, № 69, pp. 109–118. https://doi.org/10.23736/S0393-2249.16.02791-0Brassetti A., Nunzio C., Delongchamps N. Green light vaporization of the prostate: is it an adult technique? Minerva Urol Nefrol, 2017, № 69, pp. 109–118. https://doi.org/10.23736/S0393-2249.16.02791-0Bachmann A., Tubaro A., Barber N. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and ef­ficacy results of a European Multicentre Randomised Trial--the GO­LIATH study. Eur Urol., 2014, № 65, 31–42. https://doi.org/10.1016/j.eururo.2013.10.040Bachmann A., Tubaro A., Barber N. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and ef­ficacy results of a European Multicentre Randomised Trial--the GO­LIATH study. Eur Urol., 2014, № 65, 31–42. https://doi.org/10.1016/j.eururo.2013.10.040Thomas J., Tubaro A., Barber N. A Multicenter Randomized Non­inferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol., 2016, № 69, pp. 94–102. https://doi.org/10.1016/j.euru­ro.2015.07.054Thomas J., Tubaro A., Barber N. A Multicenter Randomized Non­inferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol., 2016, № 69, pp. 94–102. https://doi.org/10.1016/j.euru­ro.2015.07.054Bachmann A., Tubaro A., Barber N. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GO­LIATH study. J Urol., 2015, № 193, 570–578. https://doi.org/10.1016/j.juro.2014.09.001Bachmann A., Tubaro A., Barber N. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GO­LIATH study. J Urol., 2015, № 193, 570–578. https://doi.org/10.1016/j.juro.2014.09.001Kuntz R.M., Lehrich K., Ahyai S.A. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol., 2008, № 53, pp. 160–166. https://doi.org/10.1016/j.eururo.2007.08.036Kuntz R.M., Lehrich K., Ahyai S.A. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol., 2008, № 53, pp. 160–166. https://doi.org/10.1016/j.eururo.2007.08.036Kuntz R.M, Ahyai S., Lehrich K., Fayad A. Transurethral hol­mium laser enucleation of the prostate versus transurethral electrocau­tery resection of the prostate: a randomized prospective trial in 200 pa­tients. J Urol., 2004, № 172, pp. 1012–1016. https://doi.org/10.1097/01.ju.0000136218.11998.9eKuntz R.M, Ahyai S., Lehrich K., Fayad A. Transurethral hol­mium laser enucleation of the prostate versus transurethral electrocau­tery resection of the prostate: a randomized prospective trial in 200 pa­tients. J Urol., 2004, № 172, pp. 1012–1016. https://doi.org/10.1097/01.ju.0000136218.11998.9eFoster H.E., Barry M.J., Dahm P. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol., 2018, № 200, pp. 612–619. https://doi.org/10.1016/j.juro.2018.05.048Foster H.E., Barry M.J., Dahm P. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol., 2018, № 200, pp. 612–619. https://doi.org/10.1016/j.juro.2018.05.048Zhong J., Feng Z., Peng Y., Liang H. A Systematic Review and Me­ta-analysis of Efficacy and Safety Following Holmium Laser Enucleation of Prostate and Transurethral Resection of Prostate for Benign Prostatic Hy­perplasia. Urology, 2019, № 131, pp. 14–20. https://doi.org/10.1016/j.urol­ogy.2019.03.034Zhong J., Feng Z., Peng Y., Liang H. A Systematic Review and Me­ta-analysis of Efficacy and Safety Following Holmium Laser Enucleation of Prostate and Transurethral Resection of Prostate for Benign Prostatic Hy­perplasia. Urology, 2019, № 131, pp. 14–20. https://doi.org/10.1016/j.urol­ogy.2019.03.034Hashim H., Worthington J., Abrams P. Thulium laser transure­thral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. Lancet, 2020, 396, pp. 50–61. https://doi.org/10.1016/S0140-6736(20)30537-7Hashim H., Worthington J., Abrams P. Thulium laser transure­thral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. Lancet, 2020, 396, pp. 50–61. https://doi.org/10.1016/S0140-6736(20)30537-7Gilling P., Anderson P., Tan A. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results. J Urol., 2017, № 197, pp. 1565–1572. https://doi.org/10.1016/j.juro.2017.01.056.Gilling P., Anderson P., Tan A. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results. J Urol., 2017, № 197, pp. 1565–1572. https://doi.org/10.1016/j.juro.2017.01.056.Gilling P.J., Barber N., Bidair M. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Pros­tatic Hyperplasia: One-year Outcomes. Urology, 2019, № 125, pp. 169–173. https://doi.org/10.1016/j.urology.2018.12.002Gilling P.J., Barber N., Bidair M. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Pros­tatic Hyperplasia: One-year Outcomes. Urology, 2019, № 125, pp. 169–173. https://doi.org/10.1016/j.urology.2018.12.002Gilling P., Barber N., Bidair M. WATER: A Double-Blind, Ran­domized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol., 2018, № 199, pp. 1252– 1261. https://doi.org/10.1016/j.juro.2017.12.065Gilling P., Barber N., Bidair M. WATER: A Double-Blind, Ran­domized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol., 2018, № 199, pp. 1252– 1261. https://doi.org/10.1016/j.juro.2017.12.065Hwang E.C., Jung J.H., Borofsky M. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign pros­tatic hyperplasia. Cochrane Database Syst Rev., 2019, № 2, рр. CD013143. https://doi.org/10.1002/14651858.CD013143.pub2Hwang E.C., Jung J.H., Borofsky M. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign pros­tatic hyperplasia. Cochrane Database Syst Rev., 2019, № 2, рр. CD013143. https://doi.org/10.1002/14651858.CD013143.pub2Hoffman R.M., Monga M., Elliott S.P. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2012, рр. CD004135. https://doi.org/10.1002/14651858.CD004135.pub3Hoffman R.M., Monga M., Elliott S.P. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2012, рр. CD004135. https://doi.org/10.1002/14651858.CD004135.pub3Schelin S., Geertsen U., Walter S. Feedback microwave thermo­therapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, ran­domized, controlled, multicenter study. Urology, 2006, № 68, pp. 795–799. https://doi.org/10.1016/j.urology.2006.05.020Schelin S., Geertsen U., Walter S. Feedback microwave thermo­therapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, ran­domized, controlled, multicenter study. Urology, 2006, № 68, pp. 795–799. https://doi.org/10.1016/j.urology.2006.05.020Wagrell L., Schelin S., Nordling J. Feedback microwave thermo­therapy versus TURP for clinical BPH--a randomized controlled multi­center study. Urology, 2002, № 60, pp. 292–299. https://doi.org/10.1016/s0090-4295(02)01740-5Wagrell L., Schelin S., Nordling J. Feedback microwave thermo­therapy versus TURP for clinical BPH--a randomized controlled multi­center study. Urology, 2002, № 60, pp. 292–299. https://doi.org/10.1016/s0090-4295(02)01740-5Mattiasson A., Wagrell L., Schelin S. Five-year follow-up of feed­back microwave thermotherapy versus TURP for clinical BPH: a prospec­tive randomized multicenter study. Urology, 2007, № 69, pp. 91–96. https://doi.org/10.1016/j.urology.2006.08.1115Mattiasson A., Wagrell L., Schelin S. Five-year follow-up of feed­back microwave thermotherapy versus TURP for clinical BPH: a prospec­tive randomized multicenter study. Urology, 2007, № 69, pp. 91–96. https://doi.org/10.1016/j.urology.2006.08.1115Zhang B., Wu G., Chen C. Combination of channel-TURP and ILC versus standard TURP or ILC for elderly with benign prostatic hyperplasia: a randomized prospective trial. Urol Int., 2011, № 87, pp. 392–399. https://doi.org/10.1159/000331500Zhang B., Wu G., Chen C. Combination of channel-TURP and ILC versus standard TURP or ILC for elderly with benign prostatic hyperplasia: a randomized prospective trial. Urol Int., 2011, № 87, pp. 392–399. https://doi.org/10.1159/000331500Geavlete B., Bulai C., Ene C. Bipolar vaporization, resection, and enucleation versus open prostatectomy: optimal treatment alternatives in large prostate cases? J Endourol., 2015, № 29, pp. 323–331. https://doi.org/10.1089/end.2014.0493Geavlete B., Bulai C., Ene C. Bipolar vaporization, resection, and enucleation versus open prostatectomy: optimal treatment alternatives in large prostate cases? J Endourol., 2015, № 29, pp. 323–331. https://doi.org/10.1089/end.2014.0493Simforoosh N., Abdi H., Kashi A. Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial. Urol J, 2010, № 7, pp. 262–269.Simforoosh N., Abdi H., Kashi A. Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial. Urol J, 2010, № 7, pp. 262–269.Xie J., Tan Y., Wang F.L. Extraperitoneal laparoscopic adenomec­tomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and func­tional outcomes after 3-year follow-up. J Endourol., 2014, № 28, pp. 353– 359. https://doi.org/10.1089/end.2013.0374Xie J., Tan Y., Wang F.L. Extraperitoneal laparoscopic adenomec­tomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and func­tional outcomes after 3-year follow-up. J Endourol., 2014, № 28, pp. 353– 359. https://doi.org/10.1089/end.2013.0374

The authors declare that there are no conflicts of interest present.